Share this article and save a life!
Radiology is fighting four legislative battles at once. Here is what is actually at stake. 🏥
The Medicare fee schedule went up 3.26% in 2026. Sounds like progress. It is not. According to BC Advantage, that rate is still more than 7% lower today than it was 10 years ago.
Meanwhile, four separate bills are moving through Congress right now, and most radiology operators I talk to know maybe one of them.
Here is the full breakdown.
📋 The 4-Bill Radiology Legislation Framework (Summer 2026)
1. H.R. 8163, Provider Reimbursement Stability Act of 2026
This is the big one. It targets the structural math problem inside the Medicare Physician Fee Schedule.
Key provisions:
– Two-year lookback period to correct utilization estimates for newly unbundled codes
– Mandatory update of all direct cost inputs at least once every five years, in consultation with specialty societies
– Budget neutrality threshold adjusted from 20% (set in 1992) to 54.3% beginning in 2027, indexed to the Medicare Economic Index
– A hard cap of 2.5% on the year-to-year variance of the conversion factor
Status: 36 co-sponsors, passed out of the House Ways and Means Committee, awaiting full House vote.
This one matters most. The budget neutrality offset mechanism is why pay cuts compound over time. Fixing the threshold is the structural change, not just another one-year patch.
2. MARCA, Medicare Access to Radiology Care Act of 2026
First introduced in 2024, reintroduced May 21, 2026. If passed, it would allow physicians to bill Medicare for nondiagnostic services performed by registered radiologist assistants (RAs) under direct physician supervision.
Why it matters for workforce:
No new radiologists get trained overnight. RAs already exist in the system. This bill does not solve the shortage, but according to BC Advantage, it could help ease it by unlocking reimbursement that currently does not exist for RA-supported workflows.
One known gap in the current draft: it does not cover office-based services, which the article notes is likely an oversight.
3. H.R. 4710/S. 2420, No Surprises Act Enforcement Act
The IDR process under the No Surprises Act was supposed to resolve out-of-network payment disputes. The problem: health plans are not paying within the statutory 30-day window after losing an IDR decision.
This bill would authorize financial penalties on any party that misses those statutory deadlines. Radiology groups with significant out-of-network volume have real money sitting in limbo because of this enforcement gap.
4. H.R. 5737/S. 1692, ROOT Act
Would revive the Appropriate Use Criteria (AUC) requirement from PAMA 2014, which was removed by CMS due to administrative hurdles. The ROOT Act attempts to simplify implementation and create a physician-developed criteria system for imaging orders.
Note: the original PAMA penalty for failure to consult a Clinical Decision Support system fell on the radiologist, not the ordering physician. Enforcement in the revised version remains unclear.
📌 Save this framework. If you are heading into a budget conversation, a payer negotiation, or a practice strategy session, these four bills represent the four levers: rate stability, workforce capacity, cash collection, and utilization management.
The stakes here are not abstract.
A 7% real-dollar decline over 10 years means a group that was earning $10M in Medicare revenue in 2016 is effectively earning $9.3M today in purchasing power, before accounting for any cost inflation. The Provider Reimbursement Stability Act would not reverse that, but it would stop the bleeding.
MARCA does something different. It recognizes that you cannot close a radiologist gap with tuition loans. You close it by changing who can bill for which services inside the existing workforce.
👉 Follow Jonathan Govette, CEO of Oatmeal Health, for daily healthcare insights on LinkedIn. Deeper dives in The Oatmeal Bite on Substack: https://news.oatmealhealth.com
Share this article and save a life!
Author:

CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/




